JETB PARTNERS, LLC – Trademark Portfolio

Entity Type: 16

JETB PARTNERS, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FIDDLESTIX. The owner is based in SANTA BARBARA, CA.

798 PARK HILL LANE

SANTA BARBARA, CA 93108

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

JETB PARTNERS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

40
Treatment & Processing (1 filing)

Treatment of materials

33
Wine & Spirits (1 filing)

Alcoholic beverages (except beers)

Frequently Asked Questions

How many trademarks does JETB PARTNERS, LLC have?

JETB PARTNERS, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does JETB PARTNERS, LLC file in?

JETB PARTNERS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 40 (Treatment & Processing), Class 33 (Wine & Spirits). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are JETB PARTNERS, LLC's most well-known trademarks?

JETB PARTNERS, LLC's registered trademark portfolio includes well-known marks such as FIDDLESTIX. These are among 1 currently registered trademark in the portfolio.

What is JETB PARTNERS, LLC's trademark registration success rate?

JETB PARTNERS, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.